198 results on '"Spronk, Henri M.H."'
Search Results
2. Current and potentially novel antithrombotic treatment in acute ischemic stroke
3. Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis
4. Predictive value for increased activated factor XI activity in acute venous thromboembolism
5. Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity
6. Plasma Kallikrein as a Forgotten Clotting Factor.
7. Protein C or Protein S deficiency associates with paradoxically impaired platelet‐dependent thrombus and fibrin formation under flow
8. Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
9. Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
10. Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes
11. Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode
12. Integrating platelet and coagulation activation in fibrin clot formation
13. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19
14. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX
15. Plasma Kallikrein as a Forgotten Clotting Factor
16. Blood coagulation and beyond:Position paper from the Fourth Maastricht Consensus Conference on Thrombosis
17. Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice
18. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study
19. Distribution, genetic and cardiovascular determinants of FVIII:c — Data from the population-based Gutenberg Health Study
20. Short- and Long-term exercise induced alterations in haemostasis: a review of the literature
21. Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
22. One Thrombin Generation Method Can Monitor Both Standard and Extended Half Life FVIII Products in Haemophilia a Patients with or without Emicizumab
23. Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
24. Thrombin Generation Is Differentially Affected By Anticoagulants in Patients with Acute Lymphoblastic Leukemia - an Ex-Vivo Study
25. Lower levels of vWF are associated with lower risk of cardiovascular disease
26. Differential roles of Tissue Factor and Phosphatidylserine in activation of coagulation
27. Activation of the contact system in patients with a first acute myocardial infarction
28. Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial
29. The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test
30. Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study
31. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy
32. Biochemical determinants of thrombin generation in a general population with arterial and venous disease background
33. ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
34. Predictive Value for Increased Factor XIa and Plasma Kallikrein Activity in Acute Venous Thromboembolism
35. Chronically Elevated Interleukin-6 Disturbs the Coagulation Cascade in Mice
36. New Insights into Modulation of Thrombin Formation
37. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera
38. Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants
39. Effects of ambient air pollution on hemostasis and inflammation
40. No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation
41. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
42. The blood coagulation system as a molecular machine
43. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity
44. The Hemostatic System as a Modulator of Atherosclerosis
45. Endothelial Activation in Lacunar Stroke Subtypes
46. Is thrombin a key player in the ‘coagulation-atherogenesis’ maze?
47. Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX
48. Novel Thermostable Inhibitor of Contact Activation Tica Effectively Blocks Contact Activation in Low Tissue Factor Thrombin Generation
49. Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
50. Interrogation of the Coagulation Cascade Acute Coronary Syndrome Using Novel Elisa-Based Assays for Single Protease Quantification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.